Sunday, November 18, 2012
On May 10, 2011, long before the current deadly meningitis outbreak, an official in the FDA regional office in Denver sent an email to a colleague in Boston detailing allegations that a Massachusetts drug compounder was illegally shipping drugs to Colorado hospitals.
The information came from Colorado state inspectors who had then passed the concerns along to the U.S. Food and Drug Administration.
But there the information stopped.